Evaluation of Optimal Dose of Local Anesthetics for Patient Controlled Continuous Femoral Nerve Block

Evaluation of Optimal Dose of Local Anesthetics for Patient Controlled Continuous Femoral Nerve Block With Sciatic Nerve Block After Total Knee Arthroplasty

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01198340

Enrollment

Registered

2010-09-10

Start date

2010-09-30

Completion date

2012-06-30

Last updated

2011-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthropathy of Knee Joint

Brief summary

To evaluate an analgesic effect without basal administration of local anesthetics for patient-controlled femoral nerve block (with sciatic nerve block) after total knee arthroplasty.

Interventions

PROCEDUREPC-FNB with basal administration of local anesthetics

Administration of 0.2% ropivacaine for femoral nerve block with 3 ml/h of basal dose, 5ml bolus by the patient, 60 minutes of lock out time.

PROCEDUREPC-FNB without basal local anesthetics

Administration of 0.2% ropivacaine for femoral nerve block without basal dose, with 8 ml bolus by the patient, 60 minutes of lockout time.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Subject)

Eligibility

Sex/Gender

ALL

Age

20 Years to No maximum

Healthy volunteers

Inclusion criteria

* patients older than 20 yrs old scheduled for total knee arthroplasty

Exclusion criteria

* none

Design outcomes

Primary

Measure	Time frame
pain scores by use of numerous rating scale (NRS)	4 days after the surgery

Secondary

Measure	Time frame
dose of local anesthetics	4 days after the surgery

Countries

Japan

Contacts

Primary ContactHideki Taninishi, MD, PhD

tanishi@ops.dti.ne.jp81-86-235-7327

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026